The focus of the program project is on the behavioral and biomedical correlates of the clinical course of individuals with dementia of the Alzheimer disease (DAT) in comparison with the course of healthy aging with a focus in the distinction between healthy aging and very mild DAT. The psychometric core contributes to this effort by administering a battery of psychometric tests that assess memory (primary, secondary, and semantic)as well as visuospatial/visuoconstructive, mental control, speeded psychomotor, and language abilities. These tests are use to document the cognitive status of the research participants both at entry into the study and longitudinally as well as to support specific aims of the program projects. These include the interrelationship of behavioral (Core B), clinical (Core A), and neuropathological (Core C, Project 2) indices of Alzheimer's disease (AD). In connection with Project 1, we will provide information about normal psychological function in the oldest old as well as how to distinguish normal aging from very mild AD in very late life. Data from the Psychometric Core will be used in both Projects 3 and 4, which will focus the on the relation between specific behavioral deficits and their corresponding neuropathologic lesions. This work will address both fundamental questions of brain-behavior relations as well as the issue of individual differences in the loci of lesions/deficits in the earliest stages of AD.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG003991-23
Application #
7172969
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2006-01-01
Budget End
2006-12-31
Support Year
23
Fiscal Year
2006
Total Cost
$142,076
Indirect Cost
Name
Washington University
Department
Type
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Armstrong, Richard A; McKee, Ann C; Stein, Thor D et al. (2018) Cortical degeneration in chronic traumatic encephalopathy and Alzheimer's disease neuropathologic change. Neurol Sci :
Sato, Chihiro; Barthélemy, Nicolas R; Mawuenyega, Kwasi G et al. (2018) Tau Kinetics in Neurons and the Human Central Nervous System. Neuron 98:861-864
Deming, Yuetiva; Li, Zeran; Benitez, Bruno A et al. (2018) Triggering receptor expressed on myeloid cells 2 (TREM2): a potential therapeutic target for Alzheimer disease? Expert Opin Ther Targets 22:587-598
Millar, Peter R; Balota, David A; Bishara, Anthony J et al. (2018) Multinomial models reveal deficits of two distinct controlled retrieval processes in aging and very mild Alzheimer disease. Mem Cognit 46:1058-1075
Musiek, Erik S; Bhimasani, Meghana; Zangrilli, Margaret A et al. (2018) Circadian Rest-Activity Pattern Changes in Aging and Preclinical Alzheimer Disease. JAMA Neurol 75:582-590
Vlassenko, Andrei G; Gordon, Brian A; Goyal, Manu S et al. (2018) Aerobic glycolysis and tau deposition in preclinical Alzheimer's disease. Neurobiol Aging 67:95-98
Broce, Iris; Karch, Celeste M; Wen, Natalie et al. (2018) Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies. PLoS Med 15:e1002487
Stout, Sarah H; Babulal, Ganesh M; Ma, Chunyu et al. (2018) Driving cessation over a 24-year period: Dementia severity and cerebrospinal fluid biomarkers. Alzheimers Dement 14:610-616
Aschenbrenner, Andrew J; Gordon, Brian A; Benzinger, Tammie L S et al. (2018) Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease. Neurology 91:e859-e866
Day, Gregory S; Musiek, Erik S; Morris, John C (2018) Rapidly Progressive Dementia in the Outpatient Clinic: More Than Prions. Alzheimer Dis Assoc Disord 32:291-297

Showing the most recent 10 out of 911 publications